Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-28, Stock:JNJ, The news for the past five days is as follows:
2018-02-21: NEWS1: There Are Better Options Than Medtronic PLC Stock.NEWS2: There Are Better Options Than Medtronic PLC Stock.NEWS3: Why TG Therapeutics Stock Jumped 10% Today.NEWS4: Johnson & Johnson to start vertical construction on $18M Lake Nona facility.NEWS5: INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Johnson & Johnson of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 9, 2018.NEWS6: Can Johnson & Johnson Replace Remicade for $100 Million Upfront?.NEWS7: Can Johnson & Johnson Replace Remicade for $100 Million Upfront?.NEWS8: Can Johnson & Johnson Replace Remicade for $100 Million Upfront?.NEWS9: How Did JNJ’s Vision Care Segment Perform in 4Q17 and 2017?.NEWS10: Novartis Expects FDA and EMA Approvals for Aimovig in 2018.
2018-02-22: NEWS1: Dow Adds 165 Points; Nasdaq Suffers 4th Straight Loss.NEWS2: Dow Adds 165 Points; Nasdaq Suffers 4th Straight Loss.NEWS3: JNJ’s Consumer Products: OTC, Women’s Health, and Wound Care.NEWS4: JNJ SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Johnson & Johnson and a Lead Plaintiff Deadline of April 9, 2018.NEWS5: How Much Has Roche Paid In Dividends Over The Last Five Years?.NEWS6: How Much Has Roche Paid In Dividends Over The Last Five Years?.NEWS7: INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Johnson & Johnson To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit.NEWS8: Update on JNJ’s Consumer Products: Baby Care, Beauty, and Oral Care.NEWS9: Abbott Laboratories’ 377th Consecutive Quarterly Dividend.NEWS10: Why Is Johnson & Johnson (JNJ) Down 8.5% Since its Last Earnings Report?.NEWS11: Why Is Johnson & Johnson (JNJ) Down 8.5% Since its Last Earnings Report?.NEWS12: A Look at Eli Lilly’s 4Q17 Revenue.NEWS13: How Johnson & Johnson Performed in 4Q17 and Fiscal 2017.NEWS14: Why Is Johnson & Johnson (JNJ) Down 8.5% Since its Last Earnings Report?.NEWS15: Ex-Dividend Reminder: Johnson & Johnson, BGC Partners and KeyCorp.NEWS16: Ex-Dividend Reminder: Johnson & Johnson, BGC Partners and KeyCorp.NEWS17: February Pharma And Biotech Dividend Stocks To Look Out For.NEWS18: Why TG Therapeutics Stock Jumped 10% Today.NEWS19: Why TG Therapeutics Stock Jumped 10% Today.
2018-02-23: NEWS1: JNJ INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Johnson & Johnson and a Lead Plaintiff Deadline of April 9, 2018.NEWS2: Stocks are coiling for the next big move.NEWS3: Pawar Law Group Announces That a Class Action Lawsuit Has Been Filed On Behalf of Shareholders Who Purchased Shares of Johnson & Johnson (NYSE: JNJ) Between February 22, 2013 and February 7, 2018, Both Dates Inclusive.NEWS4: Achillion (ACHN) Q4 Loss Widens, Plans Job Cuts to Save Cost.NEWS5: Achillion (ACHN) Q4 Loss Widens, Plans Job Cuts to Save Cost.NEWS6: How Johnson & Johnson’s Infectious Diseases Portfolio Perform in 2017.NEWS7: Can brands force fix of social media's problems?.NEWS8: Achillion (ACHN) Q4 Loss Widens, Plans Job Cuts to Save Cost.NEWS9: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for February 26, 2018.NEWS10: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for February 26, 2018.NEWS11: 3 Top Dividend Stocks With Yields Over 2%.NEWS12: 3 Top Dividend Stocks With Yields Over 2%.NEWS13: Johnson & Johnson’s Simponi Could See Steady Growth in 2018.NEWS14: Performance of Johnson & Johnson’s Remicade and Stelara in 2017.NEWS15: 3 Top Dividend Stocks With Yields Over 2%.NEWS16: Jim Cramer: You Have to Decide If You Want to Profit From This Moment.
2018-02-26: NEWS1: Why Achillion Pharmaceuticals, Inc. Stock Spiked Today.NEWS2: A Deeper Look at Alkermes’ Key Marketed Products.NEWS3: Johnson & Johnson’s Oncology Segment’s Performance in 2017.NEWS4: Allergan plc. (AGN) Ex-Dividend Date Scheduled for February 27, 2018.NEWS5: Allergan plc. (AGN) Ex-Dividend Date Scheduled for February 27, 2018.NEWS6: How JNJ’s Hypertension Segment Performed in 4Q17.NEWS7: Johnson & Johnson’s Neuroscience Segment in 2017.NEWS8: Medtronic's Dominance Results in Wide Moat.
2018-02-27: NEWS1: U.S. to seek reimbursement from opioid makers, distributors.NEWS2: DOJ to support lawsuits against companies selling opioids.NEWS3: The Klein Law Firm Announces a Class Action Filed on Behalf of Johnson & Johnson Shareholders and a Lead Plaintiff Deadline of April 9, 2018 (JNJ).NEWS4: TTOO Gains Steam, LPCN Up On Upgrade, ALDX Abuzz.NEWS5: TTOO Gains Steam, LPCN Up On Upgrade, ALDX Abuzz.NEWS6: JNJ INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Johnson & Johnson.NEWS7: Johnson & Johnson Poised to Move Higher, Buy Available Weakness.NEWS8: JNJ’s Cardiovascular Segment’s Performance in 4Q17 and 2017.NEWS9: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.NEWS10: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.NEWS11: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.NEWS12: How Did Johnson & Johnson’s Zytiga Perform in 2017?.NEWS13: Darzalex Could Boost JNJ’s Revenue Growth in 2018.NEWS14: [$$] Boost Biomes Launches with Seed Round for Sustainable Farming.NEWS15: Masonite adds health care, tech industry veterans to board of directors.NEWS16: Why Achillion Pharmaceuticals, Inc. Stock Spiked Today.NEWS17: Why Achillion Pharmaceuticals, Inc. Stock Spiked Today.

Answer: Decrease